Oscar Shoenfelt, MD
Family Medicine · Baton Rouge, LANPI 1821476383
Payments from drug & device makers
Across 102 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$336
- Novo Nordisk$235
- Boehringer Ingelheim$170
- Novartis$152
- Amgen$131
- Lilly USA, LLC$112
- plus $630 from 14 others
What the payments were for
- Food & beverage$1,766100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 22 | $336 |
| Novo Nordisk | 15 | $235 |
| Boehringer Ingelheim | 6 | $170 |
| Novartis | 9 | $152 |
| Amgen | 7 | $131 |
| Lilly USA, LLC | 6 | $112 |
| AstraZeneca(2 entities) | 6 | $105 |
| Tolmar, Inc. | 5 | $94 |
| Merck | 4 | $78 |
| Phathom Pharmaceuticals, Inc. | 4 | $58 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $56 |
| Inari Medical, Inc. | 3 | $55 |
| GSK | 4 | $47 |
| Melinta Therapeutics, LLC | 2 | $30 |
| Cleerly, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| EUSA Pharma (US) LLC | 1 | $18 |
| Recordati_rare_diseases_inc. | 1 | $18 |
| Pfizer | 1 | $13 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
How this compares
$1,766 in reported general payments places this provider in the 65th percentile of 1,469 family medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 22 | $228 |
| Rosuvastatin Calcium | 20 | $183 |
| Atorvastatin Calcium | 25 | $176 |
| Levothyroxine Sodium | 17 | $156 |
| Pantoprazole Sodium | 24 | $124 |
| Metoprolol Succinate | 11 | $108 |
| Doxycycline Hyclate | 11 | $92 |
| Losartan Potassium | 12 | $65 |
| Prednisone | 23 | $55 |
| Alprazolam | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Baton Rouge
- Christine SmithBaton Rouge$185K
- Kevin DibenedettoBaton Rouge$80K
- Stan MaysBaton Rouge$15K
- Myles JaynesBaton Rouge$15K
- Yushen LeeBaton Rouge$14K
- Gerald BarberBaton Rouge$14K
- Vincent NguyenBaton Rouge$13K
- Clinton GuilloryMonroe$18.5M
- Jason MorrisLake Charles$18M
- Michael SeepLake Charles$9.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.